CPT code 0068U is a Proprietary Laboratory Analyses (PLA) code for the MycoDART–PCR™ Dual Amplification Real–Time PCR panel that identifies six Candida species from patient specimens such as blood. PLA codes are single-source, manufacturer-specific codes used to track and bill for novel or proprietary laboratory tests. Nationally, PLA codes like 0068U matter because they capture advanced molecular diagnostics that affect infectious disease detection, antimicrobial stewardship, and hospital laboratory workflows.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage considerations and benchmarking context for molecular infectious disease testing using PLA codes.

Readers will learn what CPT code 0068U represents clinically, the typical service setting for the assay, and the scope of its use for rapid detection of Candida species. The article summarizes payer coverage landscape at a national level, discusses policy and billing implications tied to PLA codes, and provides clinical context about when a rapid Candida PCR panel may be used in patient care pathways. Data not provided in the input (such as specific payer policies, reimbursement rates, or related taxonomies) is noted as unavailable.